Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wontak Kim
The CDK9 Inhibitor, Alvocidib, Potentiates the Non-Clinical Activity of Azacytidine or Decitabine in an McL-1-Dependent Fashion, Supporting Clinical Exploration of a Decitabine and Alvocidib Combination
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
The Cyclin-Dependent Kinase Inhibitor Flavopiridol (Alvocidib) Inhibits Metastasis of Human Osteosarcoma Cells
Oncotarget
Oncology
Subchronic Oral Toxicity Study of Decitabine in Combination With Tetrahydrouridine in CD-1 Mice
International Journal of Toxicology
Toxicology
Antineoplastic Effects of Decitabine, an Inhibitor of DNA Promoter Methylation, in Adrenocortical Carcinoma Cells
Archives of Surgery
Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications
PLoS ONE
Multidisciplinary
Azacytidine and Decitabine Exhibit Differential Effects on Cytotoxicity and Methylation and Exhibit Class Synergy With Hdaci in Models of PTCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Artesunate-Enhanced Apoptosis of Human High-Risk Myelodysplastic Cells Induced by the DNA Methyltransferase Inhibitor Decitabine
Oncology Letters
Cancer Research
Oncology
The Safety, Efficacy and Treatment Outcomes of a Combination of Low-Dose Decitabine Treatment in Patients With Recurrent Ovarian Cancer
OncoImmunology
Oncology
Allergy
Immunology
A Phase I Clinical Trial of FOLFIRI in Combination With the Pan-Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Role of Heme Oxygenase-1 in Demethylating Effects on SKM-1 Cells Induced by Decitabine
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
